These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35769339)
41. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis. Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192 [TBL] [Abstract][Full Text] [Related]
42. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China. Lin Y; Huang Z; Xu X; Du W; Alias H; Hu Z; Wong LP Hum Vaccin Immunother; 2022 Nov; 18(6):2126667. PubMed ID: 36165498 [TBL] [Abstract][Full Text] [Related]
44. Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey. Moeed A; Najeeb H; Saleem A; Asghar MS; Rafi HM; Khattak AK; Bilal Z; Seboka BT Front Public Health; 2022; 10():911518. PubMed ID: 35844859 [TBL] [Abstract][Full Text] [Related]
45. Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives. Jairoun AA; Al-Hemyari SS; El-Dahiyat F; Jairoun M; Shahwan M; Al Ani M; Habeb M; Babar ZU J Pharm Policy Pract; 2022 Mar; 15(1):26. PubMed ID: 35346377 [TBL] [Abstract][Full Text] [Related]
46. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey. Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184 [TBL] [Abstract][Full Text] [Related]
47. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand. Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607 [TBL] [Abstract][Full Text] [Related]
48. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study. Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y Front Immunol; 2021; 12():781161. PubMed ID: 34912346 [TBL] [Abstract][Full Text] [Related]
49. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090 [TBL] [Abstract][Full Text] [Related]
50. Willingness to receive COVID-19 booster dose and its associated factors in Ghana: A cross-sectional study. Storph RP; Essuman MA; Duku-Takyi R; Akotua A; Asante S; Armah R; Donkoh IE; Addo PA Health Sci Rep; 2023 Apr; 6(4):e1203. PubMed ID: 37064312 [TBL] [Abstract][Full Text] [Related]
51. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series. Tan KYK; Soh ASE; Ong BWL; Chen MI; Griva K Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891252 [TBL] [Abstract][Full Text] [Related]
52. Mothers' Impressions and Beliefs About Taking a Booster Dose for COVID-19 Vaccine During Pregnancy and Lactation. Taybeh EO; Alsharedeh R; Hamadneh S Cureus; 2022 Dec; 14(12):e32561. PubMed ID: 36654603 [TBL] [Abstract][Full Text] [Related]
53. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections. Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G Front Immunol; 2022; 13():863554. PubMed ID: 35711445 [TBL] [Abstract][Full Text] [Related]
54. Knowledge and attitude toward COVID-19 booster dose among health care professionals in Nepal: a cross-sectional study. Paudel K; Shah S; Bhusal S; Dahal K; Bhatta N; Pokhrel S; Dahal S; Gaihre M; Mudvari A; Gyanwali P Ann Med Surg (Lond); 2023 Apr; 85(4):772-777. PubMed ID: 37113852 [TBL] [Abstract][Full Text] [Related]
55. Iraqi Parents' Knowledge, Attitudes, and Practices towards Vaccinating Their Children: A Cross-Sectional Study. Al-Qerem W; Jarab A; Hammad A; Alasmari F; Ling J; Alsajri AH; Al-Hishma SW; Abu Heshmeh SR Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632576 [TBL] [Abstract][Full Text] [Related]
56. Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study. Deng X; Zhao Y; Wang S; He H; Chen Z; Zhou Y; Yan R; Tang X; Zhu Y; Xu X Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992290 [TBL] [Abstract][Full Text] [Related]
57. COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study. Klugar M; Riad A; Mohanan L; Pokorná A Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960183 [TBL] [Abstract][Full Text] [Related]
58. Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study. Tharwat S; Eleraky ES; Adel T; Nassar MK; Saleh M J Pharm Policy Pract; 2023 Apr; 16(1):54. PubMed ID: 37020249 [TBL] [Abstract][Full Text] [Related]
59. Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study. Yadete T; Batra K; Netski DM; Antonio S; Patros MJ; Bester JC Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960170 [TBL] [Abstract][Full Text] [Related]